Health
|
FOR IMMEDIATE RELEASE |
CONTACT: Center for Public Integrity (CPI) Steve Carpinelli (202) 481-1225 |
Painkiller Trial Raises Questions for FDA, Pfizer
Critics Charge Celebrex Study Is Unethical
WASHINGTON - March 11 -
A controversial drug trial run by a prominent doctor may unnecessarily
put patients at risk, according to a host of medical critics, who say
that the trial wouldn't be needed at all if the FDA hadn't ignored its
own advisers in a 2005 review of painkiller risks. Those are among the
findings of a new investigative report, Painkiller Trial Raises Question for FDA, Pfizer, by the Center for Public Integrity.
|
FOR IMMEDIATE RELEASE |
CONTACT: Environmental Working Group (EWG) |
EWG Updates The Pesticide Shopper’s Guide
People Can Reduce Pesticide Exposure by 80 Percent Through Smart Shopping and Using the Guide
Organic Fruit and Veggies Still Recommended
|
FOR IMMEDIATE RELEASE |
CONTACT: Doctors Without Borders (MSF) |
Call for Scale-up of R&D for Neglected Diseases
Doctors Without Borders and the Drugs for Neglected Diseases initiative Call For Greater Governmental Leadership to Foster Medical Innovation for Millions Suffering from Neglected Diseases
GENEVA/NEW YORK - February 23 - The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) and the Drugs for Neglected Diseases initiative (DNDi) called today for more sustainable funding for research and development (R&D) to tackle deadly, yet neglected diseases, such as sleeping sickness, visceral leishmaniasis, and Chagas disease, that affect millions of people around the world.